SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Veradermics reports positive Phase 3 trial of oral VDPHL01

The company said its Phase 3 '304' trial in male pattern hair loss showed early, consistent and robust hair growth.

Story updates

11:05:54 AM UTC
SquawkNews
MANE - Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304’ Clinical Trial in Male Pattern Hair Loss